ArticleBMC clinical pathology2002

A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy.

LaBaron T Washington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.